These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 16137568

  • 21. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM, Calabrese V, Calvani M, Butterfield DA.
    J Neurosci Res; 2006 Aug 01; 84(2):398-408. PubMed ID: 16634066
    [Abstract] [Full Text] [Related]

  • 22. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.
    Yan Y, Wang C.
    J Mol Biol; 2006 Dec 15; 364(5):853-62. PubMed ID: 17046788
    [Abstract] [Full Text] [Related]

  • 23. Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.
    Welander H, Frånberg J, Graff C, Sundström E, Winblad B, Tjernberg LO.
    J Neurochem; 2009 Jul 15; 110(2):697-706. PubMed ID: 19457079
    [Abstract] [Full Text] [Related]

  • 24. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ, Chen YR.
    FEBS J; 2014 Jun 15; 281(11):2674-87. PubMed ID: 24720730
    [Abstract] [Full Text] [Related]

  • 25. Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.
    Bateman DA, McLaurin J, Chakrabartty A.
    BMC Neurosci; 2007 May 02; 8():29. PubMed ID: 17475015
    [Abstract] [Full Text] [Related]

  • 26. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
    Austen BM, Paleologou KE, Ali SA, Qureshi MM, Allsop D, El-Agnaf OM.
    Biochemistry; 2008 Feb 19; 47(7):1984-92. PubMed ID: 18189413
    [Abstract] [Full Text] [Related]

  • 27. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS, Rauw G, Baker GB, Kar S.
    Eur J Neurosci; 2008 Nov 19; 28(10):1989-2002. PubMed ID: 19046381
    [Abstract] [Full Text] [Related]

  • 28. Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42.
    Zameer A, Schulz P, Wang MS, Sierks MR.
    Biochemistry; 2006 Sep 26; 45(38):11532-9. PubMed ID: 16981713
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of Abeta production by NF-kappaB inhibitors.
    Paris D, Patel N, Quadros A, Linan M, Bakshi P, Ait-Ghezala G, Mullan M.
    Neurosci Lett; 2007 Mar 19; 415(1):11-6. PubMed ID: 17223266
    [Abstract] [Full Text] [Related]

  • 30. The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.
    Giunta S, Galeazzi R, Marcellini M, Corder EH, Galeazzi L.
    Clin Biochem; 2007 Aug 19; 40(12):887-92. PubMed ID: 17512513
    [Abstract] [Full Text] [Related]

  • 31. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
    Kulic L, Kurosinski P, Chen F, Tracy J, Mohajeri MH, Li H, Nitsch RM, Götz J.
    Neurobiol Dis; 2006 Apr 19; 22(1):50-6. PubMed ID: 16289870
    [Abstract] [Full Text] [Related]

  • 32. Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity.
    Moore SA, Huckerby TN, Gibson GL, Fullwood NJ, Turnbull S, Tabner BJ, El-Agnaf OM, Allsop D.
    Biochemistry; 2004 Jan 27; 43(3):819-26. PubMed ID: 14730987
    [Abstract] [Full Text] [Related]

  • 33. The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.
    Murakami K, Masuda Y, Shirasawa T, Shimizu T, Irie K.
    Geriatr Gerontol Int; 2010 Jul 27; 10 Suppl 1():S169-79. PubMed ID: 20590832
    [Abstract] [Full Text] [Related]

  • 34. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
    Yoshiike Y, Akagi T, Takashima A.
    Biochemistry; 2007 Aug 28; 46(34):9805-12. PubMed ID: 17676931
    [Abstract] [Full Text] [Related]

  • 35. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O'Hare E, Walsh DM, Selkoe DJ.
    Ann Neurol; 2006 Dec 28; 60(6):668-76. PubMed ID: 17192927
    [Abstract] [Full Text] [Related]

  • 36. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
    Shieh PC, Tsao CW, Li JS, Wu HT, Wen YJ, Kou DH, Cheng JT.
    Neurosci Lett; 2008 Mar 21; 434(1):1-5. PubMed ID: 18313848
    [Abstract] [Full Text] [Related]

  • 37. Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.
    Tomiyama T, Asano S, Suwa Y, Morita T, Kataoka K, Mori H, Endo N.
    Biochem Biophys Res Commun; 1994 Oct 14; 204(1):76-83. PubMed ID: 7945395
    [Abstract] [Full Text] [Related]

  • 38. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Aisen PS, Saumier D, Briand R, Laurin J, Gervais F, Tremblay P, Garceau D.
    Neurology; 2006 Nov 28; 67(10):1757-63. PubMed ID: 17082468
    [Abstract] [Full Text] [Related]

  • 39. Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation.
    Kranenburg O, Bouma B, Gent YY, Aarsman CJ, Kayed R, Posthuma G, Schiks B, Voest EE, Gebbink MF.
    Mol Cell Neurosci; 2005 Mar 28; 28(3):496-508. PubMed ID: 15737740
    [Abstract] [Full Text] [Related]

  • 40. Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity.
    Fülöp L, Zarándi M, Datki Z, Soós K, Penke B.
    Biochem Biophys Res Commun; 2004 Nov 05; 324(1):64-9. PubMed ID: 15464983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.